These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8619601)

  • 21. Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
    Cormican MG; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):51-4. PubMed ID: 7789097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Ishihara S; Takahashi Y; Okezaki E; Nagata O; Saito I; Kawada Y
    J Antimicrob Chemother; 1997 Sep; 40(3):437-9. PubMed ID: 9338500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
    Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
    Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.
    Rahman M; Sultan Z; Monira S; Alam A; Nessa K; Islam S; Nahar S; Shama-A-Waris ; Alam Khan S; Bogaerts J; Islam N; Albert J
    J Clin Microbiol; 2002 Jun; 40(6):2037-40. PubMed ID: 12037060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.
    Trees DL; Sandul AL; Neal SW; Higa H; Knapp JS
    Sex Transm Dis; 2001 Jun; 28(6):309-14. PubMed ID: 11403186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
    Hamasuna R; Yasuda M; Ishikawa K; Uehara S; Hayami H; Takahashi S; Matsumoto T; Yamamoto S; Minamitani S; Watanabe A; Iwata S; Kaku M; Kadota J; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Naito S; Kuroiwa K; Hirayama H; Narita H; Hosobe T; Ito S; Ito K; Kawai S; Ito M; Chokyu H; Matsumura M; Yoshioka M; Uno S; Monden K; Takayama K; Kaji S; Kawahara M; Sumii T; Kadena H; Yamaguchi T; Maeda S; Nishi S; Nishimura H; Shirane T; Yoh M; Akiyama K; Imai T; Kano M
    J Infect Chemother; 2015 May; 21(5):340-5. PubMed ID: 25727286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.
    Barry AL; Fuchs PC; Allen SD; Jorgensen JH; Tenover FC; Murray PR; Hardy DJ; Baker CN
    J Clin Microbiol; 1993 Sep; 31(9):2375-80. PubMed ID: 8408559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
    Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
    J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan.
    Shigemura K; Okada H; Shirakawa T; Tanaka K; Arakawa S; Kinoshita S; Gotoh A; Kamidono S
    Sex Transm Infect; 2004 Apr; 80(2):105-7. PubMed ID: 15054169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.
    Dillon JA; Rubabaza JP; Benzaken AS; Sardinha JC; Li H; Bandeira MG; dos Santos Fernando Filho E
    Sex Transm Dis; 2001 Sep; 28(9):521-6. PubMed ID: 11518869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between proline-requiring auxotype and fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan.
    Tsunoe H; Tanaka M; Mochida O; Nakayama H; Kanayama A; Saika T; Kobayashi I; Naito S
    J Infect Chemother; 2001 Dec; 7(4):218-23. PubMed ID: 11810587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.
    Donegan EA; Wirawan DN; Muliawan P; Schachter J; Moncada J; Parekh M; Knapp JS
    Sex Transm Dis; 2006 Oct; 33(10):625-9. PubMed ID: 16601661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
    Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolone-resistant Neisseria gonorrhoeae: the beginning of the end? Report of quinolone-resistant isolates and surveillance in the southwestern United States, 1989 to 1997.
    Ehret JM; Judson FN
    Sex Transm Dis; 1998 Nov; 25(10):522-6. PubMed ID: 9858347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of nine fluoroquinolone antibiotics against 200 strains of enterococci.
    Murray PR; Bratcher JL; Niles AC; Hampton CM
    Diagn Microbiol Infect Dis; 1993 Jan; 16(1):83-5. PubMed ID: 8425382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
    Tanaka M; Otsuki M; Nishino T; Kobayashi I; Matsumoto T; Kumazawa J
    Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of Neisseria gonorrhoeae in Fukuoka City, Japan, in the early 1980s and 1997-1998: emergence of high-level fluoroquinolone resistance.
    Tanaka M; Naito S; Nakayama H; Kobayashi I
    Antimicrob Agents Chemother; 1999 Mar; 43(3):722-3. PubMed ID: 10070583
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
    Kim J; Ohtani H; Tsujimoto M; Sawada Y
    Drug Metab Pharmacokinet; 2009; 24(2):167-74. PubMed ID: 19430173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.